Dopamine β hydroxylase (DBH) polymorphisms do not contribute towards the clinical course of Wilson's disease in Indian patients.

Shubhrajit RoySampurna GhoshSreyashi BhattacharyaArpan SahaShyamal Kumar DasPrasanta Kumar GangopadhyayAshish BavdekarKunal RayMainak SenguptaJharna Ray

Published in: The journal of gene medicine (2019)

The data obtained in the present study suggest that the selected DBH variants are unlikely to have any significant contribution towards modifying the clinical symptoms of Indian WD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
dna methylation
patient reported outcomes
copy number
metabolic syndrome
genome wide
depressive symptoms
big data
artificial intelligence